Literature DB >> 7689149

Suppression of c-Src activity by C-terminal Src kinase involves the c-Src SH2 and SH3 domains: analysis with Saccharomyces cerevisiae.

S M Murphy1, M Bergman, D O Morgan.   

Abstract

The kinase activity of c-Src is normally repressed in vertebrate cells by extensive phosphorylation of Y-527. C-terminal Src kinase (CSK) is a candidate for the enzyme that catalyzes this phosphorylation. We have used budding yeast to study the regulation of c-Src activity by CSK in intact cells. Expression of c-Src in Saccharomyces cerevisiae, which lacks endogenous c-Src and Y-527 kinases, induces a kinase-dependent growth inhibition. Coexpression of CSK in these cells results in phosphorylation of c-Src on Y-527 and suppression of the c-Src phenotype. CSK does not fully suppress the activity of c-Src mutants lacking portions of the SH2 or SH3 domains, even though these mutant proteins are phosphorylated on Y-527 by CSK both in vivo and in vitro. These results suggest that both the SH2 and SH3 domains of c-Src are required for the suppression of c-Src activity by Y-527 phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7689149      PMCID: PMC360223          DOI: 10.1128/mcb.13.9.5290-5300.1993

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Getting started with yeast.

Authors:  F Sherman
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

2.  Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.

Authors:  M Matsuda; B J Mayer; Y Fukui; H Hanafusa
Journal:  Science       Date:  1990-06-22       Impact factor: 47.728

3.  Production of p60c-src by baculovirus expression and immunoaffinity purification.

Authors:  D O Morgan; J M Kaplan; J M Bishop; H E Varmus
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

Review 4.  Design and use of peptide substrates for protein kinases.

Authors:  B E Kemp; R B Pearson
Journal:  Methods Enzymol       Date:  1991       Impact factor: 1.600

5.  cyl encodes a putative cytoplasmic tyrosine kinase lacking the conserved tyrosine autophosphorylation site (Y416src).

Authors:  J Partanen; E Armstrong; M Bergman; T P Mäkelä; H Hirvonen; K Huebner; K Alitalo
Journal:  Oncogene       Date:  1991-11       Impact factor: 9.867

6.  Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase.

Authors:  J E Thomas; P Soriano; J S Brugge
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

7.  Cloning of three human multifunctional de novo purine biosynthetic genes by functional complementation of yeast mutations.

Authors:  D Schild; A J Brake; M C Kiefer; D Young; P J Barr
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src.

Authors:  S Nada; M Okada; A MacAuley; J A Cooper; H Nakagawa
Journal:  Nature       Date:  1991-05-02       Impact factor: 49.962

9.  Deletions in the SH2 domain of p60v-src prevent association with the detergent-insoluble cellular matrix.

Authors:  Y Fukui; M C O'Brien; H Hanafusa
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272

10.  Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice.

Authors:  P Soriano; C Montgomery; R Geske; A Bradley
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

View more
  41 in total

1.  Genetic and biochemical analysis of p23 and ansamycin antibiotics in the function of Hsp90-dependent signaling proteins.

Authors:  S P Bohen
Journal:  Mol Cell Biol       Date:  1998-06       Impact factor: 4.272

2.  Src homology domains of v-Src stabilize an active conformation of the tyrosine kinase catalytic domain.

Authors:  B Xu; W T Miller
Journal:  Mol Cell Biochem       Date:  1996-05-10       Impact factor: 3.396

3.  pp60v-src transformation of rat cells but not chicken cells strongly correlates with low-affinity phosphopeptide binding by the SH2 domain.

Authors:  M F Verderame
Journal:  Mol Biol Cell       Date:  1997-05       Impact factor: 4.138

4.  Src regulated by C-terminal phosphorylation is monomeric.

Authors:  A Weijland; J C Williams; G Neubauer; S A Courtneidge; R K Wierenga; G Superti-Furga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

5.  In vivo functions of the Saccharomyces cerevisiae Hsp90 chaperone.

Authors:  D F Nathan; M H Vos; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

6.  Identification of csk tyrosine phosphorylation sites and a tyrosine residue important for kinase domain structure.

Authors:  V Joukov; M Vihinen; S Vainikka; J M Sowadski; K Alitalo; M Bergman
Journal:  Biochem J       Date:  1997-03-15       Impact factor: 3.857

7.  Association of p62, a multifunctional SH2- and SH3-domain-binding protein, with src family tyrosine kinases, Grb2, and phospholipase C gamma-1.

Authors:  S Richard; D Yu; K J Blumer; D Hausladen; M W Olszowy; P A Connelly; A S Shaw
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

8.  Defining Human Tyrosine Kinase Phosphorylation Networks Using Yeast as an In Vivo Model Substrate.

Authors:  Thomas Corwin; Jonathan Woodsmith; Federico Apelt; Jean-Fred Fontaine; David Meierhofer; Johannes Helmuth; Arndt Grossmann; Miguel A Andrade-Navarro; Bryan A Ballif; Ulrich Stelzl
Journal:  Cell Syst       Date:  2017-08-23       Impact factor: 10.304

9.  Identification of SSF1, CNS1, and HCH1 as multicopy suppressors of a Saccharomyces cerevisiae Hsp90 loss-of-function mutation.

Authors:  D F Nathan; M H Vos; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

10.  Maturation of the tyrosine kinase c-src as a kinase and as a substrate depends on the molecular chaperone Hsp90.

Authors:  Y Xu; M A Singer; S Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.